SRC enhanced cisplatin resistance in bladder cancer by reprogramming glycolysis and pentose phosphate pathway.
Gong Y, Gao D, Shi Y, Fan G, Yu X, Yang E, Cheng H, Tian J, Ding H, Liu S, Fu S, Tao Y, Shui Y, Cheng L, Li L, Wang Z.
Gong Y, et al. Among authors: shi y.
Commun Biol. 2025 Jan 10;8(1):36. doi: 10.1038/s42003-024-07284-1.
Commun Biol. 2025.
PMID: 39794543